Gemcitabine enhances cell invasion via activating HAb18G/CD147-EGFR-pSTAT3 signaling

Pancreatic cancer, one of the most lethal cancers, has very poor 5-year survival partly due to gemcitabine resistance. Recently, it was reported that chemotherapeutic agents may act as stressors to induce adaptive responses and to promote chemoresistance in cancer cells. During long-term drug treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Bao-Qing, Fu, Zhi-Guang, Meng, Yao, Wu, Xiao-Qing, Wu, Bo, Xu, Liang, Jiang, Jian-Li, Li, Ling, Chen, Zhi-Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308719/
https://www.ncbi.nlm.nih.gov/pubmed/27556697
http://dx.doi.org/10.18632/oncotarget.11405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308719/
https://www.ncbi.nlm.nih.gov/pubmed/27556697
http://dx.doi.org/10.18632/oncotarget.11405

Ejemplares similares